Loading…
Natera, Inc. is projected to rise to $379.35 by 2027, a +35% move from its current price of $281.85. NTRA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $275.04 | $282.01 | $289.16 | +0.06% |
| Jul 13 | $272.36 | $282.18 | $292.35 | +0.12% |
| Jul 14 | $270.36 | $282.34 | $294.86 | +0.17% |
| Jul 15 | $268.71 | $282.51 | $297.01 | +0.23% |
| Jul 16 | $267.28 | $282.67 | $298.95 | +0.29% |
| Jul 17 | $266.01 | $282.84 | $300.73 | +0.35% |
| Jul 18 | $264.86 | $283.00 | $302.38 | +0.41% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $264.86 | $283.00 | $302.38 | +0.41% |
| Week 2 | $258.74 | $284.16 | $312.06 | +0.82% |
| Week 3 | $254.39 | $285.31 | $320.00 | +1.23% |
| Week 4 | $250.93 | $286.48 | $327.06 | +1.64% |
| Week 5 | $248.04 | $287.65 | $333.58 | +2.06% |
| Week 6 | $245.56 | $288.82 | $339.71 | +2.47% |
| Week 7 | $243.38 | $290.00 | $345.56 | +2.89% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Natera, Inc. is a diagnostics company that develops and commercializes molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test.
In addition, the company provides Panorama, a non-invasive prenatal test; Horizon, a carrier screening test; Fetal Focus, a single-gene NIPT, or sgNIPT, that screens for 21 single-gene inherited conditions; and Vistara, a single-gene NIPT, which screens for 25 single-gene conditions. It also offers Anora, which tests and analyzes miscarriage tissue from women who have experienced one or more pregnancy losses; Empower, a hereditary cancer screening test; Prospera, a test to assess active rejection in patients who have undergone solid organ transplantation; Renasight, a kidney gene panel test; and Constellation software, a cloud-based distribution model.
The company provides NateraCore, a platform to support the patient and provider experience; phlebotomy services; and EMR integration services. It serves independent laboratories, national and regional reference laboratories, medical centers and physician practices for its screening tests, research laboratories, and pharmaceutical companies through its direct sales force and laboratory distribution partners, as well as Constellation licensees under its cloud-based distribution model. Natera was founded in 2003 and is headquartered in Austin, Texas.
It was formerly known as Gene Security Network, LLC and changed its name to Natera, Inc. in January 2012.
Natera, Inc. (NTRA) currently trades at $279.32 per share with a market capitalization of $39.57B and a market rank of 5438. The stock’s near-term outlook is supported by a bullish technical tone and a strong price action context.
The forecast envisions substantial upside across multiple years, with a 2050 average price of $5,914.57 and a max of $10,683.70, signaling a pronounced long-run upside potential.
A year-by-year forecast indicates a path of rising values beyond 2026, highlighting continued bullish sentiment through the coming decades. This sets a backdrop for investors considering mid- to long-term exposure to this diagnostics leader.
A major floor 35.2% below — a decisive break under it would weaken the trend.
The nearest floor, 24.8% below — buyers have tended to step in here.
Price is pressing into resistance (0.7% away) — a breakout level to watch.
A major ceiling 16.1% above — clearing it would confirm fresh momentum.
Key NTRA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NTRA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $278.25 | Buy | $275.46 | Buy |
| MA 10 | $275.25 | Buy | $270.87 | Buy |
| MA 20 | $253.15 | Buy | $257.77 | Buy |
| MA 50 | $225.52 | Buy | $235.67 | Buy |
| MA 100 | $214.11 | Buy | $223.12 | Buy |
| MA 200 | $213.15 | Buy | $209.71 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 62.40 | Neutral |
| Stoch RSI (14) | 13.33 | Buy |
| CCI (20) | 47.57 | Neutral |
| Williams %R (14) | -25.18 | Info |
| MACD (12,26,9) | 0.77 | Buy |
| ROC (12) | 14.99 | Buy |
| Bollinger %B (20,2) | 0.67 | Neutral |
| Stochastic %K (14) | 74.82 | Neutral |
| TRIX (15) | 1.04 | Buy |
| Awesome (5,34) | 41.64 | Buy |
| Ultimate (7,14,28) | 57.24 | Neutral |
| Momentum (10) | 9.21 | Buy |
| Aroon Osc (25) | 84.00 | Buy |
| Hull MA (9) | 277.46 | Buy |
| ADX (14) | 32.89 | Buy |
| ATR (14) | 6.06 | Info |
The 30-day technical picture is bullish. RSI(14) is 80, indicating strong momentum, while the short-term moving averages reinforce upside potential. The 50-day moving average sits at $218.04 and the 200-day moving average sits at $210.65, signaling constructive trend alignment for a continued advance.
Near-term support is indicated at $200.91, with resistance at $279.32. The 30-day price range spans from $235.91 to $330.72, highlighting a broad trading corridor during the period. Overall, the sentiment remains bullish as momentum has persisted above key moving averages and price action respects the defined support and resistance levels.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $182.65 | $281.85 | $372.61 | 0% | Neutral | |
| $304.32 | $379.35 | $498.84 | +35% | Bullish | |
| $373.13 | $477.06 | $649.20 | +69% | Bullish | |
| $485.48 | $633.87 | $886.09 | +125% | Bullish | |
| $579.92 | $771.28 | $1,102.90 | +174% | Bullish | |
| $605.79 | $819.34 | $1,195.07 | +191% | Bullish | |
| $706.62 | $970.74 | $1,441.31 | +244% | Bullish | |
| $789.68 | $1,100.83 | $1,661.06 | +291% | Bullish | |
| $820.86 | $1,160.28 | $1,776.97 | +312% | Bullish | |
| $1,045.55 | $1,497.59 | $2,325.45 | +431% | Bullish | |
| $1,546.36 | $2,351.59 | $3,869.60 | +734% | Bullish | |
| $3,530.23 | $5,945.11 | $10,649.53 | +20.1x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $182.65 | $281.85 | $334.23 | +0.00% |
| August 2026 | $243.77 | $287.13 | $346.86 | +1.87% |
| September 2026 | $250.72 | $297.21 | $362.71 | +3.51% |
| October 2026 | $248.08 | $295.69 | $363.97 | -0.51% |
| November 2026 | $243.44 | $291.51 | $361.41 | -1.41% |
| December 2026 | $248.25 | $298.56 | $372.61 | +2.42% |
Click any year to see its month-by-month NTRA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, NTRA could reach as high as $372.61, with a base case around $281.85 and support toward $182.65 — roughly 0% from $281.85. Price action looks broadly range-bound.
Expect NTRA to range from $304.32 to $498.84 through 2027. The $379.35 average target implies a +35% move from current prices. That is up +35% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The NTRA price prediction for 2028 points to an average of $477.06 (low $373.13, high $649.20) — a potential gain of +69% on today's $281.85. Momentum favours further upside here.
In 2029, NTRA is projected to trade between $485.48 and $886.09, averaging $633.87 — a potential gain of +125% from today's $281.85. That is up +33% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Natera, Inc.'s 2030 outlook centres on $771.28, within a $579.92 to $1,102.90 range. That is up +22% on the projected 2029 average. That marks a +174% change versus current levels. Momentum favours further upside here.
By 2031, NTRA could reach as high as $1,195.07, with a base case around $819.34 and support toward $605.79 — roughly +191% from $281.85. Buyers look set to stay in control over this stretch.
Expect NTRA to range from $706.62 to $1,441.31 through 2032. The $970.74 average target implies a +244% move from current prices. That is up +18% on the projected 2031 average. Momentum favours further upside here.
The NTRA price prediction for 2033 points to an average of $1,100.83 (low $789.68, high $1,661.06) — a potential gain of +291% on today's $281.85. Buyers look set to stay in control over this stretch.
In 2034, NTRA is projected to trade between $820.86 and $1,776.97, averaging $1,160.28 — a potential gain of +312% from today's $281.85. That is up +5% on the projected 2033 average. Momentum favours further upside here.
Natera, Inc.'s 2035 outlook centres on $1,497.59, within a $1,045.55 to $2,325.45 range. That is up +29% on the projected 2034 average. That marks a +431% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, NTRA could reach as high as $3,869.60, with a base case around $2,351.59 and support toward $1,546.36 — roughly +734% from $281.85. Momentum favours further upside here.
Expect NTRA to range from $3,530.23 to $10,649.53 through 2050. The $5,945.11 average target implies a +20.1x move from current prices. That is up +153% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in NTRA today (≈ 3.547987 NTRA) could be worth
$21,093.19
+$20,093.19 (+2009%) by 2050 · US Dollar
Based on the average projected NTRA price of $5,945.11 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NTRAwould be worth at today's price.
$1,000 invested in NTRA on Jul 10, 2025 (≈ 6.12145 NTRA) would be worth
$1,725.33
+$725.33 (+72.5%) today · 1.73× · US Dollar
Based on a NTRA entry price of $163.36 vs. today's $281.85.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $279.32 | $1,009.06 | +0.9% |
| 1 month ago | $216.5 | $1,301.85 | +30.2% |
| 3 months ago | $193.03 | $1,460.14 | +46.0% |
| 6 months ago | $235.45 | $1,197.07 | +19.7% |
| 1 year ago | $163.36 | $1,725.33 | +72.5% |
| All time (5.0y) ago | $119.51 | $2,358.38 | +135.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NTRA forecast.
Our base-case forecast reaches $560.00 around 2029.
Implied market cap at $560.00: $80.2B
2030 forecast: average price $762.57, with a low of $571.04 and a high of $1,095.76, and an ROI of 173. The sentiment is BULLISH for this horizon.
2040 forecast: average price $2,332.55, with a low of $1,521.89 and a high of $3,865.59, and an ROI of 735.1. The sentiment remains BULLISH across this longer horizon.
2050 forecast: average price $5,914.57, with a low of $3,473.21 and a high of $10,683.70, and an ROI of 2017.5. The sentiment is BULLISH for the far horizon.
These figures are projected outcomes and reflect estimates of price trajectories over the indicated years. They imply substantial long-run upside but are not guarantees and should be considered within a framework of risk and uncertainty inherent in financial forecasts.
Tap a question to reveal the answer.
The forecast shows a 2030 average price of $762.57, with a range from $571.04 to $1,095.76, and an implied ROI of 173. The sentiment for 2030 is BULLISH.
The forecast indicates ongoing bullish sentiment in 2027–2035 with rising average prices and sizeable ROIs (for example, 2027 avg $375.04, 2029 avg $634.33, 2030 avg $762.57). These are estimates and not guarantees.
Yes. The 2030 maximum forecast is $1,095.76, which exceeds $1,000. The 2030 minimum forecast is $571.04 and the 2029 maximum forecast is $890.75, illustrating a path that can cross the $1,000 mark in the 2030 horizon.
Current price: $279.32. Market cap: $39.57B. The stock is ranked 5438.
The 30-day picture is bullish. RSI(14) is 80, SMA50 is $218.04, SMA200 is $210.65. Support sits at $200.91 and resistance at $279.32, with a 30-day range from $235.91 to $330.72.
Natera, Inc. Community Discussion
0Share your Natera, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.